Literature DB >> 1673101

Plasmodium falciparum: genetic stability of the Uganda Palo Alto strain propagated in the squirrel monkey (Saimiri sciureus).

T Fandeur1, O Mercereau-Puijalon.   

Abstract

The Uganda Palo Alto strain of Plasmodium falciparum has been extensively used in several laboratories to infect Saimiri monkeys. In the study reported here three distinct lines derived by parallel serial blood transfers from a single 10-year-old passage of the Palo Alto strain were examined for genetic diversity using the polymerase chain reaction and restriction mapping techniques. A comparison of the PF 11.1, P190, MSA2, S-Ag, and KAHRP genes indicates that these parasite lines are apparently homogeneous and stable. Nevertheless, microheterogeneity was observed with molecular probes which are known to easily detect restriction fragment length polymorphisms (rep 20 and telomeric probes). These data show that the genetic characters of the strain can be considered monomorphic and are conserved after multiple passages in the squirrel monkey.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1673101     DOI: 10.1016/0014-4894(91)90141-i

Source DB:  PubMed          Journal:  Exp Parasitol        ISSN: 0014-4894            Impact factor:   2.011


  3 in total

1.  A primary malarial infection is composed of a very wide range of genetically diverse but related parasites.

Authors:  P Druilhe; P Daubersies; J Patarapotikul; C Gentil; L Chene; T Chongsuphajaisiddhi; S Mellouk; G Langsley
Journal:  J Clin Invest       Date:  1998-05-01       Impact factor: 14.808

2.  Protection of squirrel monkeys against virulent Plasmodium falciparum infections by use of attenuated parasites.

Authors:  T Fandeur; J Gysin; O Mercereau-Puijalon
Journal:  Infect Immun       Date:  1992-04       Impact factor: 3.441

3.  Immune pressure selects for Plasmodium falciparum parasites presenting distinct red blood cell surface antigens and inducing strain-specific protection in Saimiri sciureus monkeys.

Authors:  T Fandeur; C Le Scanf; B Bonnemains; C Slomianny; O Mercereau-Puijalon
Journal:  J Exp Med       Date:  1995-01-01       Impact factor: 14.307

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.